Barriers and determinants of postpartum family planning uptake among postpartum women in western Ethiopia: a cross-sectional facility study

This article was originally published here

Arch Public Health. 2022 Jan 12;80(1):27. doi: 10.1186/s13690-022-00786-6.


BACKGROUND: Despite Ethiopia’s efforts to benefit from postpartum family planning (PPFP) services, the unmet need for family planning among postpartum women remains high. Therefore, this study aims to assess the barriers and determinants of postpartum family planning uptake among women visiting maternal, newborn, and child health (MNCH) services in public health facilities in western from Ethiopia.

METHODS: A facility-based cross-sectional study design with a quantitative method was conducted on 989 postpartum women in Western Ethiopia from September 1 to October 30, 2020. Data were collected through interviews face-to-face using pretested structured questionnaires, entered using EPI-INFO version 7.0, and analyzed by SPSS version 25. Descriptive analysis and logistic regressions were performed. Odds ratio adjusted with 95% confidence interval was used and statistical significance was declared at P

RESULT: In this study, 56.1% of participants had used PPFP in the past year. The most commonly used method was the injectable (51.7%). Use of family planning before pregnancy index (AOR = 2.09; 95% CI: 1.29, 3, 41), counseling on PPFP during antenatal care and delivery (AOR = 4.89; CI at 95%: 2.31, 10.37), delivery in a health facility (AOR = 7.61; 95% CI: 4.36, 13.28), skilled attendance at birth (AOR = 7.61; = 4.99; 95% CI: 2.88, 8.64), COVID-19 restrictions (AOR = 0.59; 95% CI: 0.39, 0.90) were factors associated with Using the PPFP. Breastfeeding and amenorrhea were the main reasons for not using postpartum family planning.

CONCLUSION: Use of postpartum family planning among study participants was low. Given the associated factors, it is recommended that health facilities make postpartum family planning one of their top priorities and focus on these factors to improve its use.

PMID:35022070 | DO I:10.1186/s13690-022-00786-6

Comments are closed.